SOFT TISSUE SARCOMA ADULT
Clinical trials for SOFT TISSUE SARCOMA ADULT explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA ADULT trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Immune-Boosting drug tested with chemo to fight advanced sarcoma
Disease control Recruiting nowThis study is testing whether adding an experimental immunotherapy drug called retifanlimab to standard chemotherapy (gemcitabine and docetaxel) is safe and more effective for treating advanced soft tissue sarcoma. The goal is to see if the combination can better control the canc…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Personalized radiation aims to spare sarcoma patients from Long-Term side effects
Disease control Recruiting nowThis study is testing whether selecting certain patients to receive proton radiation instead of standard X-ray radiation before sarcoma surgery can reduce long-term side effects while maintaining the same treatment effectiveness. For each of the 110 adult participants in Norway, …
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Proton beam trial aims to zap inoperable tumors with higher, safer doses
Disease control Recruiting nowThis study is testing whether a newer type of radiation therapy, called proton beam therapy, can be given at a higher dose to better control inoperable soft tissue sarcomas. The goal is to see if this approach stops tumor growth for at least two years without increasing side effe…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New hope for Tough-to-Treat sarcomas: Dual-Attack drug trial
Disease control Recruiting nowThis trial is testing whether combining two existing cancer drugs—pembrolizumab and cabozantinib—can help control advanced sarcomas that have stopped responding to standard treatments. It will enroll about 119 adults with specific types of advanced sarcoma. The main goal is to se…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Scientists hunt for clues to personalize sarcoma treatment
Knowledge-focused Recruiting nowThis study aims to understand how personalized chemotherapy given before surgery works for patients with high-risk soft tissue sarcoma. Researchers will collect and analyze tissue samples from 800 patients, comparing those who receive chemotherapy before surgery to those who have…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated Apr 03, 2026 19:40 UTC